Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals ...

Citi analyst Daniel Grosslight maintained a Hold rating on Cardinal Health (CAH – Research Report) today and set a price target of $140.00. The company’s shares closed yesterday at $134.36.

Cardinal Health (CAH) closed at $133.69 in the latest trading session, marking a +1.92% move from the prior day. The stock's performance was behind the S&P 500's daily gain of 2.51%. Elsewhere ...

Complaints provide insights to improve product quality, ensure compliance, and drive growth. Cardinal Health is transforming complaint management by centralizing data, improving visibility, and ...

View Cardinal Health, Inc. (CAH) current and estimated P/E ratio data provided by Seeking Alpha.

In November, Cardinal Health acquired a majority stake in GI Alliance for $2.8 billion, one of the largest transactions in the gastroenterology space in recent years. Here are five key takeaways from ...

Cardinal Health has been selected as a distributor for Telix Pharmaceuticals' Gozellix®, an important development for the company, particularly in the U.S. market. Over the last quarter ...